UPSA, the effervescence laboratory

UPSA, founded in 1935, is a leading pharmaceutical company in Europe, focusing on family medication. With a large industrial site in Agen, UPSA develops, manufactures, and markets medicines for pain, minor ailments, and sleep disorders. Also known as the effervescence laboratory, UPSA is known to be the first to have launched Normogastryl, the first effervescent drug for gastric disorders. UPSA offers brands like Polysilane, Dafalgan, Efferalgan, and Fervex. With a presence in over 60 countries, UPSA exports nearly 40% of its volumes annually from Agen, showcasing its “Made in France” expertise, available in Mauritius with Scott Health.